Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by Chianchinon Aug 10, 2023 5:33pm
149 Views
Post# 35582728

The locus/aliases are out...

The locus/aliases are out...en mass with all kinds of excuses as I had predicted.   The bottom line the marked pooped on the news. Further what the promoters/beg holders do not understand is that LATAM sadly is poor very poor with average income below $10K and cannot absorb higher prices that is why the margins are low and will remain low. Then there is inflation, currency depreciation and best of all political corruption and a lot of crime. The wind or trend or market is not in favor and the thicker tape response is clear. Gud should have never bought GBT at any price. GUD market cap before buying GBT was over 1.6 billion and cash was over 900 million. Now GUD market cap is below $500 millions, cash 100 million which is mostly washed out by 70 million in debt. It may take a lifetime or two for these losing promoter beg holder to breakeven on this investment. Mr. Meir predicted such. Increase sales must be followed by higher margin and profit and not loses. Otherwise what is the point of selling more goods and services years later
<< Previous
Bullboard Posts
Next >>